Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease

James A. Solomon, Michael Oswalt, Michael Nodzenski, Julie Glener, Matthew R. Schaeffer, Todd V. Cartee, Ian A. Maher, Joseph F. Sobanko, Abigail Waldman, Simon S Yoo, Suzanna Lewis, Morgan Barr, Molly Marous, Brigitte Sledge, Jodi Kay Duke, April W. Armstrong, Emily Poon Samuelson, Emir Veledar, Robert P. Dellavalle, Murad Alam

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Recent increase in skin biopsies has been attributed to an epidemic of skin cancer. This may be avoidable, with potential savings. OBJECTIVE: To determine whether the increase in skin biopsies is attributable to increasing frequency of biopsies associated with histology lacking pathological cutaneous disease. Pathological cutaneous disease was defined as (1) a malignancy, precancerous lesion, or lesion of uncertain behavior; or (2) disease symptomatic or associated with adverse quality of life impact. PATIENTS AND METHODS: Retrospective cohort study, 2006 to 2013 of dermatology practice serving Florida and Ohio. Data were a consecutive sample of skin biopsies for diagnosis of dermatologic disease. RESULTS: A total of 267,706 biopsies by an average of 52 providers per month from January 06 to December 13 were analyzed. Number of biopsies per visit increased 2% per year (RR: 1.02, CI: 1.00-1.04). Likelihood of biopsy associated with histology indicative of nonpathological cutaneous disease did not increase over time (OR: 0.99, CI: 0.95-1.03, p = .6302). CONCLUSION: Rates of biopsies associated with nonpathological cutaneous disease is not increasing. Overall biopsy rates per visit have gradually increased; this seems attributable to greater rates of detection of pathological dermatologic disease.

Original languageEnglish (US)
Pages (from-to)640-649
Number of pages10
JournalDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Volume45
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Skin Diseases
Biopsy
Skin
Histology
Skin Neoplasms
Dermatology
Cohort Studies
Retrospective Studies
Quality of Life

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Solomon, James A. ; Oswalt, Michael ; Nodzenski, Michael ; Glener, Julie ; Schaeffer, Matthew R. ; Cartee, Todd V. ; Maher, Ian A. ; Sobanko, Joseph F. ; Waldman, Abigail ; Yoo, Simon S ; Lewis, Suzanna ; Barr, Morgan ; Marous, Molly ; Sledge, Brigitte ; Duke, Jodi Kay ; Armstrong, April W. ; Samuelson, Emily Poon ; Veledar, Emir ; Dellavalle, Robert P. ; Alam, Murad. / Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease. In: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2019 ; Vol. 45, No. 5. pp. 640-649.
@article{edc883458a11425b9e7a9dfaf2689ca8,
title = "Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease",
abstract = "BACKGROUND: Recent increase in skin biopsies has been attributed to an epidemic of skin cancer. This may be avoidable, with potential savings. OBJECTIVE: To determine whether the increase in skin biopsies is attributable to increasing frequency of biopsies associated with histology lacking pathological cutaneous disease. Pathological cutaneous disease was defined as (1) a malignancy, precancerous lesion, or lesion of uncertain behavior; or (2) disease symptomatic or associated with adverse quality of life impact. PATIENTS AND METHODS: Retrospective cohort study, 2006 to 2013 of dermatology practice serving Florida and Ohio. Data were a consecutive sample of skin biopsies for diagnosis of dermatologic disease. RESULTS: A total of 267,706 biopsies by an average of 52 providers per month from January 06 to December 13 were analyzed. Number of biopsies per visit increased 2{\%} per year (RR: 1.02, CI: 1.00-1.04). Likelihood of biopsy associated with histology indicative of nonpathological cutaneous disease did not increase over time (OR: 0.99, CI: 0.95-1.03, p = .6302). CONCLUSION: Rates of biopsies associated with nonpathological cutaneous disease is not increasing. Overall biopsy rates per visit have gradually increased; this seems attributable to greater rates of detection of pathological dermatologic disease.",
author = "Solomon, {James A.} and Michael Oswalt and Michael Nodzenski and Julie Glener and Schaeffer, {Matthew R.} and Cartee, {Todd V.} and Maher, {Ian A.} and Sobanko, {Joseph F.} and Abigail Waldman and Yoo, {Simon S} and Suzanna Lewis and Morgan Barr and Molly Marous and Brigitte Sledge and Duke, {Jodi Kay} and Armstrong, {April W.} and Samuelson, {Emily Poon} and Emir Veledar and Dellavalle, {Robert P.} and Murad Alam",
year = "2019",
month = "5",
day = "1",
doi = "10.1097/DSS.0000000000001865",
language = "English (US)",
volume = "45",
pages = "640--649",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "5",

}

Solomon, JA, Oswalt, M, Nodzenski, M, Glener, J, Schaeffer, MR, Cartee, TV, Maher, IA, Sobanko, JF, Waldman, A, Yoo, SS, Lewis, S, Barr, M, Marous, M, Sledge, B, Duke, JK, Armstrong, AW, Samuelson, EP, Veledar, E, Dellavalle, RP & Alam, M 2019, 'Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease', Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], vol. 45, no. 5, pp. 640-649. https://doi.org/10.1097/DSS.0000000000001865

Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease. / Solomon, James A.; Oswalt, Michael; Nodzenski, Michael; Glener, Julie; Schaeffer, Matthew R.; Cartee, Todd V.; Maher, Ian A.; Sobanko, Joseph F.; Waldman, Abigail; Yoo, Simon S; Lewis, Suzanna; Barr, Morgan; Marous, Molly; Sledge, Brigitte; Duke, Jodi Kay; Armstrong, April W.; Samuelson, Emily Poon; Veledar, Emir; Dellavalle, Robert P.; Alam, Murad.

In: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], Vol. 45, No. 5, 01.05.2019, p. 640-649.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease

AU - Solomon, James A.

AU - Oswalt, Michael

AU - Nodzenski, Michael

AU - Glener, Julie

AU - Schaeffer, Matthew R.

AU - Cartee, Todd V.

AU - Maher, Ian A.

AU - Sobanko, Joseph F.

AU - Waldman, Abigail

AU - Yoo, Simon S

AU - Lewis, Suzanna

AU - Barr, Morgan

AU - Marous, Molly

AU - Sledge, Brigitte

AU - Duke, Jodi Kay

AU - Armstrong, April W.

AU - Samuelson, Emily Poon

AU - Veledar, Emir

AU - Dellavalle, Robert P.

AU - Alam, Murad

PY - 2019/5/1

Y1 - 2019/5/1

N2 - BACKGROUND: Recent increase in skin biopsies has been attributed to an epidemic of skin cancer. This may be avoidable, with potential savings. OBJECTIVE: To determine whether the increase in skin biopsies is attributable to increasing frequency of biopsies associated with histology lacking pathological cutaneous disease. Pathological cutaneous disease was defined as (1) a malignancy, precancerous lesion, or lesion of uncertain behavior; or (2) disease symptomatic or associated with adverse quality of life impact. PATIENTS AND METHODS: Retrospective cohort study, 2006 to 2013 of dermatology practice serving Florida and Ohio. Data were a consecutive sample of skin biopsies for diagnosis of dermatologic disease. RESULTS: A total of 267,706 biopsies by an average of 52 providers per month from January 06 to December 13 were analyzed. Number of biopsies per visit increased 2% per year (RR: 1.02, CI: 1.00-1.04). Likelihood of biopsy associated with histology indicative of nonpathological cutaneous disease did not increase over time (OR: 0.99, CI: 0.95-1.03, p = .6302). CONCLUSION: Rates of biopsies associated with nonpathological cutaneous disease is not increasing. Overall biopsy rates per visit have gradually increased; this seems attributable to greater rates of detection of pathological dermatologic disease.

AB - BACKGROUND: Recent increase in skin biopsies has been attributed to an epidemic of skin cancer. This may be avoidable, with potential savings. OBJECTIVE: To determine whether the increase in skin biopsies is attributable to increasing frequency of biopsies associated with histology lacking pathological cutaneous disease. Pathological cutaneous disease was defined as (1) a malignancy, precancerous lesion, or lesion of uncertain behavior; or (2) disease symptomatic or associated with adverse quality of life impact. PATIENTS AND METHODS: Retrospective cohort study, 2006 to 2013 of dermatology practice serving Florida and Ohio. Data were a consecutive sample of skin biopsies for diagnosis of dermatologic disease. RESULTS: A total of 267,706 biopsies by an average of 52 providers per month from January 06 to December 13 were analyzed. Number of biopsies per visit increased 2% per year (RR: 1.02, CI: 1.00-1.04). Likelihood of biopsy associated with histology indicative of nonpathological cutaneous disease did not increase over time (OR: 0.99, CI: 0.95-1.03, p = .6302). CONCLUSION: Rates of biopsies associated with nonpathological cutaneous disease is not increasing. Overall biopsy rates per visit have gradually increased; this seems attributable to greater rates of detection of pathological dermatologic disease.

UR - http://www.scopus.com/inward/record.url?scp=85065391327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065391327&partnerID=8YFLogxK

U2 - 10.1097/DSS.0000000000001865

DO - 10.1097/DSS.0000000000001865

M3 - Article

VL - 45

SP - 640

EP - 649

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 5

ER -